| Question 27 | |
| Question 10 | Cellulitis, but more broadly, ICU admission decisionmaking |
| Question 27 | Fluid resuscitation and fluid responsiveness in sepsis |
| Question 18 | |
| Question 14 | CLABSI, and how to salvage central access when infected |
| Question 12 | |
| Question 11 | Cytomegalovirus: clinical features, diagnosis, initial drug treatment |
| Question 27 | |
| Question 14 | Positive blood cultures: real vs contaminant |
| Question 8 | COVID-19 - PCR, coinfection, immunosuppression |
| Question 22 | Meningococcal sepsis: risk factors, features, management, complications |
| Question 20 | |
| Question 18 | Corticosteroids in community-acquired pneumonia |
| Question 17 | Pneumocystis jirovecii pneumonia |
| Question 13 | Legionella species: transmission, diagnosis, management, prevention. |
| Question 30 | |
| Question 7 | Immune suppression: timing of infection following transplant |
| Question 27 | |
| Question 21 | |
| Question 4 | Empyema; also vancomycin vs. linezolid |
| Question 28.3 | Cytomegalovirus: specifically, colitis |
| Question 28.2 | |
| Question 28.1 | "Name That Microbe": Gram-positive cocci in the CSF |
| Question 26 | |
| Question 21.3 | Malaria: diagnosis, severity features, management |
| Question 22 | |
| Question 1 | Staphylococcal bacteraemia: assessment and management |
| Question 27 | Necrotising fasciitis - specifically, associated with Group A Streptococci |
| Question 5 |
| Question 23 | |
| Question 12 | Tuberculosis: investigations and infection control precautions |
| Question 21.3 | Cryptococcus meningitis in a patient with AIDS |
| Question 21.2 | Listeria monocytogenes meningitis |
| Question 21.1 | CSF analysis in meningitis |
| Question 26 | Meningitis - in a neonate, but without a paediatric flavour |
| Question 25 | |
| Question 1 |
| Question 15.1 | Approach to the hideous whole-body rash - purpura fulminans again |
| Question 13 | Ventilator-associated pneumonia: nebulised antibiotics |
| Question 6.3 | Meningitis - when not to LP |
| Question 6.2 | Meningitis - ventriculitis |
| Question 6.1 | Meningitis - microbiology and investigations |
| Question 4 |
| Question 30.1 | Clinical diagnosis of infective endocarditis |
| Question 21 | |
| Question 20 | |
| Question 4 |
| Question 4 | |
| Question 2 | Community-acquired pneumonia: risk stratification |
| Question 21 | |
| Question 18 | |
| Question 14 | |
| Question 6 | Tetanus, again! |
| Question 15.2 | Management of meningitis post trans-sphenoidal surgery |
| Question 14 | Name that organism: cultures from a festering pancreatitis patient |
| Question 28 | Sepsis in the heart and lung transplant recipient - a pneumonia, of course |
| Question 9 | |
| Question 6 | Biomarkers of sepsis: procalcitonin in some detail |
| Question 2 | Necrotising fasciitis - specifically, associated with Group A Streptococci |
| Question 30.2 | Listeria: a game of "Name That Microbe". Also, risk factors and treatment options. |
| Question 30.1 | Mucor: a game of "Name That Microbe". Also, risk factors and treatment options. |
| Question 25 | Necrotising fasciitis: management priorities within the first 24 hours |
| Question 5 | Community-acquired pneumonia: critically evaluate the role of steroids |
| Question 1 | Severe acute pancreatitis: role of antibiotics |
| Question 22 | Viral haemorrhagic fever (Ebola) |
| Question 19 | |
| Question 12 | |
| Question 10 | Pharmacokinetics of antibiotics in critical illness: specifically, in septic shock |
| Question 28 | |
| Question 27 | General principles of antibiotic use: factors which influence the choice of agent |
| Question 21.2 | Antibiotic choices for selected pathogens: specific context of meningitis |
| Question 19 | HIV and AIDS: relevant investigations and antiretroviral pharmacology |
| Question 11 | Meningitis: specifically, common pathogens and role of steroids |
| Question 5 | Management of the staff member with a needle stick injury. |
| Question 29.1 | Clinical features of infective endocarditis other than fever and murmur. |
| Question 18 | All about the significance of the endothelial glycocalyx in sepsis. |
| Question 9 | Aspergillosis: specifically, issues related to its diagnosis |
| Question 7 | Leptospirosis, in frightening detail |
| Question 3.3 | |
| Question 3.2 | |
| Question 3.1 | |
| Question 1 |
| Question 11 | Sepsis in the bone marrow transplant recipient (also, causes of diarrhoea) |
| Question 3.3 | Acronymous organisms: ESCAPPM and HACEK organisms again. |
| Question 3.2 | Necrotising fasciitis of the abdominal wall. Also a game of "Name That Microbe." |
| Question 1 |
| Question 22 | Critically evaluate the role of vasopressin in resuscitation of septic shock. |
| Question 16 | |
| Question 15.2 | Antibiotic dosing in renal failure (for patients who are not on dialysis) |
| Question 15.1 | |
| Question 12 | Tetanus! Specific management of tetanus. |
| Question 23.3 | "Name That Microbe" - specifically, which Gram-negatives have innate imipenem resistance |
| Question 23.2 | Vibrio vulnificus: a game of "Name That Microbe" |
| Question 19 | H1N1 "Swine Flu" influenza - diagnosis and management. |
| Question 16 | Corticosteroids in septic shock, again. |
| Question 9 |
| Question 7 | Community-acquired pneumonia: evaluation of the non-resolving pneumonia. |
| Question 3.3 | Meningitis in general; specifically, aseptic meningitis. |
| Question 18 | Community-acquired pneumonia: prognosis, organisms, empiric treatment. |
| Question 6 | Haemoptysis in an abattoir worker; another game of "Name That Microbe". |
| Question 25 | Malaria: diagnosis, management and complications |
| Question 19 | |
| Question 18 | Which antibiotic choice would be appropriate (abdominal catastrophe) |
| Question 24 | Necrotising fasciitis: "management priorities" |
| Question 11 | Which antibiotic choice would be appropriate for these MROs. |
| Question 21 | Cytomegalovirus infection in the immunocompetent patient. |
| Question 17.3 | |
| Question 17.2 | "Name That Microbe": Historical features associated with specific pathogens |
| Question 17.1 | Choice of appropriate antibiotics for this list of organisms. |
| Question 14.2 | |
| Question 14.1 | Necrotising fasciitis: Fournier's gangrene. 2 important management steps. |
| Question 23 | Critical evaluation of procalcitonin; a variant of the biomarkers of sepsis |
| Question 13 |
| Question 25.4 | "Name That Microbe": pneumonia, arthralgia and a new murmur in a cattle farmer |
| Question 25.3 | "Name That Microbe": which Gram-negatives have innate imipenem resistance? |
| Question 25.2 | "Name That Microbe": which Gram-positive bacillus is causing this meningitis ? |
| Question 20 | Clinical features and management of malaria. |
| Question 9 |
| Question 29.1 | |
| Question 25.3 | |
| Question 25.2 | |
| Question 25.1 | Necrotising fasciitis of the abdominal wall. |
| Question 22 | |
| Question 21 | Noradrenaline in resuscitation of septic shock; also calculation of the SVR. |
| Question 25.3 | "Name That Microbe": Pneumonia arthralgia and a new murmur in a cattle farmer |
| Question 25.2 | Acronymous organisms: ESCAPPM and HACEK organisms again. |
| Question 25.1 | "Name That Microbe": Gram-positive bacillus in the CSF |
| Question 17 | Acalculous cholecystitis: clinical features, investigations and management |
| Question 12 | |
| Question 11.2 | "Does this CSF look infected to you?" ... a case of meningitis |
| Question 24.3 | Acronymous organisms: ESCAPPM and HACEK organisms again. |
| Question 24.2 | Which antibiotic choice would be appropriate to treat this Proteus infection? |
| Question 24.1 | |
| Question 22 | |
| Question 21 | Infective endocarditis. Particularly, what are the indications for emergency valve replacement? |
| Question 13 | Which antibiotic choice would be appropriate (abdominal catastrophe). |
| Question 1 |
| Question 27 | The difficulty in making a diagnosis of sepsis; also, lets talk about biomarkers of sepsis |
| Question 25 | Management of the staff member with a needle stick injury. |
| Question 19 |
| Question 26 | Community acquired pneumonia: specifically, historical features of special relevance. |
| Question 7 | Inotropes in resuscitation of septic shock: comparison of adrenaline, dopamine and dobutamine. |
| Question 13 | SARS pneumonia: risk factors and management strategies. |
| Question 2b | Infectious and non-infectious causes of fever: a post-operative scenario |
| Question 3 | Pharmacology of antifungal agents: Fluconazole; "critically evaluate" fluconazole. |
| Question 2d | Community acquired pneumonia: when to escalate or de-escalate antibiotics. |
| Question 2c | Community acquired pneumonia: empiric antibiotic therapy. |
| Question 2b | Community-acquired pneumonia: investigations. |
| Question 2a | Community-acquired pneumonia: historical features |
| Question 9 | Pneumonia in the immunocompromised host: specifically, in AIDS. |
| Question 10 | |
| Question 8 | Acalculous cholecystitis: clinical features, investigations and management |
| Question 1 | Infectious and non-infectious causes of fever and the management of fever. |
| Question 1 | Necrotising fasciitis: diagnostic features and priorities of management. |
| Question 10 | Corticosteroids in septic shock (or...refractory shock in general?) |
| Question 5 | Antibiotic pharmacology - compare benzylpenicillin, ciprofloxacin and cotrimoxazole |
| Question 13 | Malaria. Discuss management. |
| Question 1 | Pharmacokinetics and pharmacodynamics of antibiotics in critical illness. |